U.S., Aug. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07118202) titled 'TheraBionic P1 Device in Subjects With Advanced Hepatocellular Carcinoma' on Aug. 05.
Brief Summary: The goal of this clinical trial is to learn if the TheraBionic P1 device given to patients with advanced hepatocellular carcinoma (HCC) who have no standard of care options can affect patients survival. The main questions it aims to answer are:
* will the TheraBionic P1 device affect overall survival in advance HCC
* the long term safety and tolerability of the TheraBionic P1 device
* assessment of how the disease responded to the TheraBionic P1 device
Study Start Date: Aug. 31
Study Type: INTERVENTIONAL
Condition:
Hepatocellu...